PRVA vs. HIMS, RDNT, OPCH, GH, SHC, VCYT, BTSG, LFST, SGRY, and CON
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Hims & Hers Health (HIMS), RadNet (RDNT), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.
Privia Health Group vs.
Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.
Privia Health Group received 26 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 75.28% of users gave Privia Health Group an outperform vote while only 39.05% of users gave Hims & Hers Health an outperform vote.
In the previous week, Hims & Hers Health had 20 more articles in the media than Privia Health Group. MarketBeat recorded 24 mentions for Hims & Hers Health and 4 mentions for Privia Health Group. Hims & Hers Health's average media sentiment score of 0.64 beat Privia Health Group's score of 0.36 indicating that Hims & Hers Health is being referred to more favorably in the news media.
94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 14.2% of Privia Health Group shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Privia Health Group presently has a consensus target price of $24.88, indicating a potential upside of 11.88%. Hims & Hers Health has a consensus target price of $25.13, indicating a potential downside of 9.60%. Given Privia Health Group's stronger consensus rating and higher possible upside, research analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.
Privia Health Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Privia Health Group has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500.
Hims & Hers Health has a net margin of 8.19% compared to Privia Health Group's net margin of 0.75%. Hims & Hers Health's return on equity of 10.97% beat Privia Health Group's return on equity.
Summary
Privia Health Group beats Hims & Hers Health on 10 of the 19 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:PRVA) was last updated on 1/20/2025 by MarketBeat.com Staff
Free PRVA Stock Alerts